The Open Targets Blog

SEPTEMBER 21, 2023

After completing my PhD in organic chemistry at the University of Cambridge, I went to Canada as a Leverhulme Trust postdoctoral fellow. For example, there are often many potential targets you could consider developing a treatment against for a given disease; how do you choose between them? I’m a chemist by training.

Organic Chemistry 82

Organic Chemistry Process Chemistry Small Molecule Science 82

The Pharma Data

OCTOBER 23, 2020

A graduate of the Hebrew University of Jerusalem, he earned a Bachelor of Science in chemistry and physics and a Master of Science in physical organic chemistry before completing a Doctor of Philosophy in 1971. Dr. Elmaleh has contributed to more than 130 book chapters, scientific papers, and professional journal articles.

Organic Chemistry 52

Organic Chemistry Clinical Trials Science Pharmaceuticals 52

Drug Target Review

MARCH 8, 2025

Throughout her career, Bakrania has held pivotal roles at renowned companies, including Biohaven, where she contributed to the development of therapies, such as migraine treatment Nurtec ODT. Her expertise in regulatory strategy and process development has been instrumental in advancing important treatments.

Science 59

Science Organic Chemistry Process Chemistry Therapies 59